Council for Innovation Promotion

Inventor Spotlight: Charles W. Hull

C4IP is honoring Charles W. Hull (born 1939), who has transformed manufacturing, medicine, and design through his invention of stereolithography — better known as 3D printing. Hull was born in Clifton, Colorado, and studied engineering physics at the University of Colorado before joining Ultraviolet Products, a company that used UV light to solidify liquid plastic […]

Inventor Spotlight: Charles W. Hull Read More »

Council for Innovation Promotion Urges Congress to Oppose the ETHIC Act

WASHINGTON (August 5, 2025) — Senators Peter Welch (D-VT), Josh Hawley (R-MO), and Amy Klobuchar (D-MN) recently introduced the Eliminating Thickets to Increase Competition (ETHIC) Act, S. 2276, in the U.S. Senate. This legislation would prohibit patent holders, specifically in the pharmaceutical sector, from asserting more than one patent out of a certain defined group

Council for Innovation Promotion Urges Congress to Oppose the ETHIC Act Read More »

Council for Innovation Promotion Applauds the EC’s Definitive Withdrawal of Standard Essential Patents Proposal

WASHINGTON (August 4, 2025) — Today, the Council for Innovation Promotion (C4IP) applauds the European Commission’s decision to decisively withdraw its proposed regulations on standard essential patents (SEPs). The proposal risked undermining innovation in Europe, the United States, and elsewhere, as well as the current system of industry-led negotiations based on fair, reasonable, and nondiscriminatory

Council for Innovation Promotion Applauds the EC’s Definitive Withdrawal of Standard Essential Patents Proposal Read More »

Fact Check: Setting the Record Straight on Standard-Essential Patents and Innovation

Earlier this year, a coalition of technology industry lobbyists sent a letter to President Trump urging his administration to weaken protections for standard-essential patents (SEPs) — patents that protect innovations incorporated into common, standardized technologies like 5G and Wi-Fi. Their letter reflected longstanding false narratives about SEPs and claimed that weakening SEP rights would benefit

Fact Check: Setting the Record Straight on Standard-Essential Patents and Innovation Read More »

Why C4IP Opposes the Drug Competition Enhancement Act and the Affordable Prescriptions for Patients Act

Congress is currently considering several ill-conceived bills that purport to address abuses in the patent system, but would, in reality, weaken core intellectual property protections. Among them are the Drug Competition Enhancement Act (S. 1040) and the Affordable Prescriptions for Patients Act (S. 1041). By attempting to devalue the United States’ robust intellectual property system,

Why C4IP Opposes the Drug Competition Enhancement Act and the Affordable Prescriptions for Patients Act Read More »

What the Numbers Say: Patent Quality in the United States is Strong

A newly-released policy brief from the IP Policy Institute at the University of Akron School of Law reaffirms the finding from a 2024 Sunwater Institute report that overall patent quality in the United States is high. The Sunwater Institute study found that the USPTO grants invalid patents only 7% of the time — an impressively

What the Numbers Say: Patent Quality in the United States is Strong Read More »

Scroll to Top